Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products

Bone Marrow Transplantation

Volumn 23, Issue 1, 1999, Pages 53-62

  Singh, R K ^a   Ino, K ^a   Varney, M L ^a   Heimann, D G ^a   Talmadge, J E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bone marrow; Cytokines; Gene regulation; Immunomodulators; Stem cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE; MALE; MESSENGER RNA SYNTHESIS; MONOCYTE; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033006821     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701518     Document Type: Article

References (42)

1. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high dose therapy for malignancies. Blood 1991; 77: 211-213.
2. Kessinger A. Is blood or bone marrow better? Stem Cells 1993; 11: 290-295.
3. Kessinger A. Circulating stem cells: waxing hematopoietic. New Engl J Med 1995; 333: 315-316.
4. Sheridan WP. Transplantation of mobilized peripheral blood stem cells: role of filgrastim. J Hemother 1994; 3: 349-352.
5. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. New Engl J Med 1995; 333: 283-285.
6. Vose JM, Anderson JR, Kessinger A et al. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1846-1851.
7. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
8. Talmadge JE, Reed E, Ino K et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 10: 161-172.
9. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
10. To LB, Roberts M, Haylock D. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
11. Guillaume T, Sekhavat M, Rubinstein DB et al. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Res 1994; 54: 3800-3807.
12. Talmadge JE, Reed EC, Kessinger A et al. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101-109.
13. Mills KC, Gross TG, Varney ML et al. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. Bone Marrow Transplant 1996; 18: 53-61.
14. Kawano Y, Takaue Y, Saito S et al. Granulocyte colony stimulating factor (G-CSF), macrophage-CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts. Blood 1993; 81: 856-860.
15. Ho AD, Maruyama M, Maghazachi A et al. Soluble CD4, soluble CD8, soluble CD25, lymphopoietic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation. Blood 1994; 84: 3550-3557.
16. Testa U, Martucci R, Rutella S et al. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 1994; 84: 3532-3539.
17. Takamatsu Y, Akashi K, Harada M et al. Cytokine production by peripheral blood monocytes and T cells during haemopoietic recovery after intensive chemotherapy. Br J Haematol 1993; 83: 21-27.
18. Watts MJ, Jones HM, Sullivan AM et al. Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation. Br J Haematol 1995; 91: 767-772.
19. Baiocchi GP, Scambia G, Benedetti G et al. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recover. Cancer Res 1993; 53: 1297-1303.
20. Cairo MS, Gillan ER, Weinthal J et al. Decreased endogenous circulating steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment. Bone Marrow Transplant 1993; 11: 155-161.
21. Haas R, Gericke G, Witt B et al. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation. Exp Hematol 1993; 21: 109-113.
22. Miksits K, Beyer J, Siegert W. Serum concentrations of G-CSF during high-dose chemotherapy with autologous stem cell rescue. Bone Marrow Transplant 1993; 11: 375-377.
23. Welte K, Ciobanu N, Moore MAS et al. Defective interleukin-2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin-2. Blood 1984; 64: 380-385.
24. Schneider LC, Antin JH, Weinstein H et al. Lymphokine profile in bone marrow transplant recipients. Blood 1991; 78: 3076-3080.
25. Romagnani S. Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Appl Immunol 1992; 98: 279-287.
26. Romagnani S. Human Th1 and Th2 subsets doubt no more. Immunol Today 1991; 12: 251-256.
27. Paul WE, Seder RA. Lymphocyte response and cytokine. Cell 1994; 76: 241-251.
28. Romagnani S. Th1 and Th2 T helper cells: functions, regulation, and role in protection and disease. Intl J Clin Lab Res 1991; 21: 152-158.
29. Lederer JA, Liou JS, Todd MD et al. Regulation of cytokine gene expression in T helper cell subsets. J Immunol 1994; 152: 77-87.
30. Spagnoli GC, Juretic A, Schultz-Thater E et al. On the relative roles of IL-2 and IL-10 in generation of lymphokine activated killer cell activity. Cell Immunol 1993; 146: 391-405.
31. Yamamura M, Modlin RL, Ohmen JD, Moy R. Local expression of antiinflammatory cytokines in cancer. J Clin Invest 1993; 91: 1005-1010.
32. Kharkevitz DD, Seito D, Balch GC et al. Characterization of autologous-specific T helper 2 cells in tumor infiltrating lymphocytes from patients with metastatic melanoma. Int J Cancer 1994; 58: 317-323.
33. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-325.
34. Ino K, Singh RK, Talmadge JE. Monocytes from mobilized stem cell products induce T-cell apoptosis. J Leukocyte Biol 1997; 61: 583-591.
35. Chomczynski P, Sacchi N. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
36. Kessinger A, Armitage J, Antman K (eds). Re-establishing hematopoiesis after dose-intensive therapy with peripheral stem cells. High Dose Cancer Therapy. Williams and Wilkins: Baltimore, 1992, pp 102.
37. Janssen WE, Smilee RC, Elfenbein GJ. A prospective randomized trial comparing blood- and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy. J Hematother 1995; 4: 139-140.
38. Kiesel S, Pezzutto A, Moldenhaur G et al. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation. Blood 1988; 72: 672-678.
39. To LB, Juttner C, Stomski F et al. Immune reconstitution following peripheral blood stem cell autografting. Bone Marrow Transplant 1987; 2: 111-112.
40. Lum LG, Joshi ID, Smith MR et al. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact. Bone Marrow Transplant 1994; 13: 187-195.
41. Tomioka H, Sato K, Maw WW, Saito H. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J Leukocyte Biol 1995; 58: 704-712.
42. Singh RK, Ageitos AG, Ino K et al. Fas-FasL mediated T cell apoptosis by monocytes and peripheral tolerance in patients undergoing high dose chemotherapy and stem cell transplantation. Acta Hematol 1997; 98 (Suppl. 1): 85.